Show simple item record

dc.contributor.authorWorld Health Organization, Regional Office for South-East Asia
dc.coverage.spatialNew Delhien_US
dc.date.accessioned2016-04-13T10:21:02Z
dc.date.available2016-04-13T10:21:02Z
dc.date.issued1999
dc.identifier.urihttp://www.who.int/iris/handle/10665/205177
dc.description.abstractIn the past 15 years, we have witnessed a dramatic increase in the global incidence of dengue and its severe manifestations such as dengue haemorrhagic fever (‎DHF)‎ and dengue shock syndrome (‎DSS)‎. increasing magnitude. More than 2.5 billion people are at risk of infections in over 200 countries worldwide. There are probably tens of millions of cases of dengue each year, and at least five hundred thousand cases of DHF with a mortality of about five per cent in most countries. The vast majority of cases, nearly 95 per cent, are among children of less than 15 years of age. Clearly this infection, which is already the most widespread mosquito -borne disease in humans, is of major public health importance. The present guidelines on treatment of DF/DHF in small hospitals have been developed by WHO, in consultation with the leading experts in the field of clinical management of DHF. I am sure, these guidelines will be a proper tool for physicians working in small hospitals to conduct appropriate treatment of patients with DF/DHF, and would help in achieving our common target to reduce case fatality rate of DHF to less than one per cent in all endemic countries.en_US
dc.language.isoenen_US
dc.publisherWHO Regional Office for South-East Asiaen_US
dc.subjectDENGUEen_US
dc.titleGuidelines for treatment of dengue fever/dengue haemorrhagic fever in small hospitalsen_US
dc.typePublicationsen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record